High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
Open Access
- 1 March 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (3) , 243-246
- https://doi.org/10.1023/a:1008252227512
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukapheresesJournal of Clinical Apheresis, 1996
- High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplantsBlood, 1994
- High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.Journal of Clinical Oncology, 1994
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- Autologous Bone Marrow Transplantation for Multiple MyelomaHematology/Oncology Clinics of North America, 1992
- Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.Journal of Clinical Oncology, 1992
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983